Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension

Chronic pulmonary hypertension leads to structural alterations of the lung vessels. The pathophysiology of this remodelling process is still poorly understood. Furthermore, the structural damage of the lung vessels limits the clinical success of vasodilator treatment. Given a genetic susceptibility, shear stress and inflammation are the principal pathogenetic factors involved in lung vessel remodelling. In this overview, we compared the lung vascular histology of patients with unexplained pulmonary hypertension, scleroderma, or acquired immune deficiency syndrome (AIDS)-associated pulmonary hypertension. We demonstrate the presence of inflammatory cells (T- and B-lymphocytes and macrophages) in plexiform lesions and discuss the potential role of growth factors (platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-beta) and vascular endothelial growth factor (VEGF) in pulmonary hypertensive remodelling. Ultimately, we need to develop an in-depth understanding of the key mechanisms of gene expression and signalling pathways, which transduce signals generated from increased chronic shear stress (or from chronic hypoxia) and lead to vascular injury and repair.

This article has been cited by other articles:

				S. J. Wort, M. Ito, P.-C. Chou, S. K. Mc Master, R. Badiger, E. Jazrawi, P. de Souza, T. W. Evans, J. A. Mitchell, L. Pinhu, et al. Synergistic Induction of Endothelin-1 by Tumor Necrosis Factor {alpha} and Interferon {gamma} Is due to Enhanced NF-{kappa}B Binding and Histone Acetylation at Specific {kappa}B Sites J. Biol. Chem., September 4, 2009; 284(36): 24297 - 24305. [Abstract] [Full Text] [PDF]

				N. Selimovic, C-H. Bergh, B. Andersson, E. Sakiniene, H. Carlsten, and B. Rundqvist Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension Eur. Respir. J., September 1, 2009; 34(3): 662 - 668. [Abstract] [Full Text] [PDF]

				C. A. Nold-Petry, M. F. Nold, J. A. Zepp, S.-H. Kim, N. F. Voelkel, and C. A. Dinarello IL-32-dependent effects of IL-1{beta} on endothelial cell functions PNAS, March 10, 2009; 106(10): 3883 - 3888. [Abstract] [Full Text] [PDF]

				W. Wu, N. B. Dave, G. Yu, P. J. Strollo, E. Kovkarova-Naumovski, S. W. Ryter, S. R. Reeves, E. Dayyat, Y. Wang, A. M. K. Choi, et al. Network analysis of temporal effects of intermittent and sustained hypoxia on rat lungs Physiol Genomics, December 12, 2008; 36(1): 24 - 34. [Abstract] [Full Text] [PDF]

				A. Zakrzewicz, F. M. Kouri, B. Nejman, G. Kwapiszewska, M. Hecker, R. Sandu, E. Dony, W. Seeger, R. T. Schermuly, O. Eickelberg, et al. The transforming growth factor-{beta}/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension Eur. Respir. J., June 1, 2007; 29(6): 1094 - 1104. [Abstract] [Full Text] [PDF]

				B. Beghe, E. Bazzan, S. Baraldo, F. Calabrese, F. Rea, M. Loy, P. Maestrelli, R. Zuin, L. M. Fabbri, and M. Saetta Transforming growth factor-{beta} type II receptor in pulmonary arteries of patients with very severe COPD Eur. Respir. J., September 1, 2006; 28(3): 556 - 562. [Abstract] [Full Text] [PDF]

				M. R. Nicolls, L. Taraseviciene-Stewart, P. R. Rai, D. B. Badesch, and N. F. Voelkel Autoimmunity and pulmonary hypertension: a perspective Eur. Respir. J., December 1, 2005; 26(6): 1110 - 1118. [Abstract] [Full Text] [PDF]

				H. Lepetit, S. Eddahibi, E. Fadel, E. Frisdal, C. Munaut, A. Noel, M. Humbert, S. Adnot, M-P. D'Ortho, and C. Lafuma Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension Eur. Respir. J., May 1, 2005; 25(5): 834 - 842. [Abstract] [Full Text] [PDF]

				M. Bonay, C. Bancal, D. de Zuttere, F. Arnoult, G. Saumon, and F. Camus Normal Pulmonary Capillary Blood Volume in Patients With Chronic Infiltrative Lung Disease and High Pulmonary Artery Pressure Chest, November 1, 2004; 126(5): 1460 - 1466. [Abstract] [Full Text] [PDF]

				J. L. Wright, H. Tai, and A. Churg Cigarette Smoke Induces Persisting Increases of Vasoactive Mediators in Pulmonary Arteries Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 501 - 509. [Abstract] [Full Text] [PDF]

				D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF]

				C. D. Cool, P. R. Rai, M. E. Yeager, D. Hernandez-Saavedra, A. E. Serls, T. M. Bull, M. W. Geraci, K. K. Brown, J. M. Routes, R. M. Tuder, et al. Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension N. Engl. J. Med., September 18, 2003; 349(12): 1113 - 1122. [Abstract] [Full Text] [PDF]

				J.A. Barbera, V.I. Peinado, and S. Santos Pulmonary hypertension in chronic obstructive pulmonary disease Eur. Respir. J., May 1, 2003; 21(5): 892 - 905. [Abstract] [Full Text] [PDF]

				Y. Yu, M. Sweeney, S. Zhang, O. Platoshyn, J. Landsberg, A. Rothman, and J. X.-J. Yuan PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression Am J Physiol Cell Physiol, February 1, 2003; 284(2): C316 - C330. [Abstract] [Full Text] [PDF]

				A.T. Dinh-Xuan, M. Humbert, and R. Naeije Severe pulmonary hypertension: walking through new paths to revisit an old field Eur. Respir. J., September 1, 2002; 20(3): 509 - 510. [Full Text] [PDF]

				B. Raychaudhuri, A. Malur, T. L. Bonfield, S. Abraham, R. J. Schilz, C. F. Farver, M. S. Kavuru, A. C. Arroliga, and M. J. Thomassen The Prostacyclin Analogue Treprostinil Blocks NFkappa B Nuclear Translocation in Human Alveolar Macrophages J. Biol. Chem., August 30, 2002; 277(36): 33344 - 33348. [Abstract] [Full Text] [PDF]

				P. DORFMULLER, V. ZARKA, I. DURAND-GASSELIN, G. MONTI, K. BALABANIAN, G. GARCIA, F. CAPRON, A. COULOMB-LHERMINE, A. MARFAING-KOKA, G. SIMONNEAU, et al. Chemokine RANTES in Severe Pulmonary Arterial Hypertension Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 534 - 539. [Abstract] [Full Text] [PDF]

				M. W. Geraci, M. Moore, T. Gesell, M. E. Yeager, L. Alger, H. Golpon, B. Gao, J. E. Loyd, R. M. Tuder, and N. F. Voelkel Gene Expression Patterns in the Lungs of Patients With Primary Pulmonary Hypertension : A Gene Microarray Analysis Circ. Res., March 30, 2001; 88(6): 555 - 562. [Abstract] [Full Text] [PDF]

				J R Thomson and R C Trembath Primary pulmonary hypertension: the pressure rises for a gene J. Clin. Pathol., December 1, 2000; 53(12): 899 - 903. [Abstract] [Full Text] [PDF]

				E. Papakonstantinou, G. Karakiulakis, M. Tamm, A. P. Perruchoud, and M. Roth Hypoxia modifies the effect of PDGF on glycosaminoglycan synthesis by primary human lung cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L825 - L834. [Abstract] [Full Text] [PDF]

				N. J. Mehta, I. A. Khan, R. N. Mehta, and D. A. Sepkowitz HIV-Related Pulmonary Hypertension : Analytic Review of 131 Cases Chest, October 1, 2000; 118(4): 1133 - 1141. [Abstract] [Full Text] [PDF]

				M. Liu, A. K. Tanswell, and M. Post Mechanical force-induced signal transduction in lung cells Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L667 - L683. [Abstract] [Full Text] [PDF]

				C. D. Fike and M. R. Kaplowitz Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L449 - L456. [Abstract] [Full Text] [PDF]

				K. B. Jourdan, T. W. Evans, N. J. Lamb, P. Goldstraw, and J. A. Mitchell Autocrine Function of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Proliferation of Human and Rat Pulmonary Artery Smooth-Muscle Cells . Species Variation Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 105 - 110. [Abstract] [Full Text]

				V. I. PEINADO, J. A. BARBERA, P. ABATE, J. RAMIREZ, J. ROCA, S. SANTOS, and R. RODRIGUEZ-ROISIN Inflammatory Reaction in Pulmonary Muscular Arteries of Patients with Mild Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1605 - 1611. [Abstract] [Full Text] [PDF]

				F Bellotto, P Chiavacci, F Laveder, A Angelini, G Thiene, and R Marcolongo Effective immunosuppressive therapy in a patient with primary pulmonary hypertension Thorax, April 1, 1999; 54(4): 372 - 374. [Abstract] [Full Text]

				M. Tamm, M. Bihl, O. Eickelberg, P. Stulz, A. P. Perruchoud, and M. Roth Hypoxia-Induced Interleukin-6 and Interleukin-8 Production Is Mediated by Platelet-Activating Factor and Platelet-Derived Growth Factor in Primary Human Lung Cells Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 653 - 661. [Abstract] [Full Text]

				M. V. Cutaia, N. Parks, J. Centracchio, S. Rounds, K. P. Yip, and A. M. Sun Effect of hypoxic exposure on Na+/H+ antiport activity, isoform expression, and localization in endothelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 1998; 275(3): L442 - L451. [Abstract] [Full Text] [PDF]

				V. I. Peinado, J. A. Barbera, J. Ramirez, F. P. Gomez, J. Roca, L. Jover, J. M. Gimferrer, and R. Rodriguez-Roisin Endothelial dysfunction in pulmonary arteries of patients with mild COPD Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L908 - L913. [Abstract] [Full Text] [PDF]

				P. LESPRIT, B. GODEAU, F.-J. AUTHIER, M. SOUBRIER, M. ZUBER, C. LARROCHE, J.-P. VIARD, B. WECHSLER, and R. GHERARDI Pulmonary Hypertension in POEMS Syndrome . A New Feature Mediated by Cytokines Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 907 - 911. [Abstract] [Full Text] [PDF]

				M. W. Lame, A. D. Jones, D. W. Wilson, S. K. Dunston, and H. J. Segall Protein Targets of Monocrotaline Pyrrole in Pulmonary Artery Endothelial Cells J. Biol. Chem., September 8, 2000; 275(37): 29091 - 29099. [Abstract] [Full Text] [PDF]

				J. R. Hamilton, A. G. Frauman, and T. M. Cocks Increased Expression of Protease-Activated Receptor-2 (PAR2) and PAR4 in Human Coronary Artery by Inflammatory Stimuli Unveils Endothelium-Dependent Relaxations to PAR2 and PAR4 Agonists Circ. Res., July 6, 2001; 89(1): 92 - 98. [Abstract] [Full Text] [PDF]